On September 26, 2022, AIM ImmunoTech Inc. announced that it began mailing the mailer to stockholders of the Company along with copies of the Amendment No. 1 to the Company's definitive proxy statement and accompanying revised the Company proxy card, which were filed with the U.S. Securities and Exchange Commission on September 21, 2022.